MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT FREE T3; FREE TRIIODOTHYRONINE

Catalog Number	07K63-27
Medical Device Problem Code	Low Test Results (2458)
Health Effect - Clinical Code	No Known Impact Or Consequence To Patient (2692)
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
Patient sid; (b)(6).All available patient information were included, no additional patient information was available.Correction/removal number= 3005094123-10/22/18-001-c.Product correction letters were issued on 12oct2018 to all architect total t3 (tt3) and free t3 (ft3) customers, using the i1000sr, i2000, or i2000sr instruments and who received one of the impacted lots.The letter instructed the customers to prevent this interaction by either separating the architect ft3 and/or architect tt3 assays by running these tests on different instruments from the following assays architect tsh, architect t-uptake, architect hiv ag/ab combo, architect cortisol, architect lh, architect progrp, architect rhtlv-i/ii, architect total psa, architect afp, and architect free psa, architect 25-oh vitamin d, or by performing daily maintenance on the instrument prior to performing batch testing for all ft3 and/or tt3 samples.The mechanism of carryover involves carryover of poly-l-lysine (pll) from other assays into the conjugate dispense step in the ft3 and tt3 assays through adherence of the pipetting probe.
Event or Problem Description
The customer reported false decreased free t3 results of <1.5 ng/ml for patient samples and bio-rad controls out of range low, when processing on the architect i2000.The following data was provided.Sid (b)(6): initial < 1.5 pg/ml, repeat 1.79 pg/ml, sid xxxx: initial 1.55 pg/ml, repeat < 1.5 pg/ml, (b)(6) <1.5 pg/ml , (b)(6)<1.5 pg/ml , (b)(6) <1.5 pg/ml.Samples were repeated with the reagent lot 08328ui00 and obtained identical results.Per the product package insert, the measuring interval limit of quantitation is 1.5 pg/ml and the results were correctly flagged with a less than sign, <.No impact to patient management was reported.

• Brand Name: ARCHITECT FREE T3
• Common Device Name: FREE TRIIODOTHYRONINE
• Manufacturer (Section D): ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD; lisnamuck; co. longford; longford NA ; EI NA
• MDR Report Key: 9805481
• Report Number: 3005094123-2020-00068
• Device Sequence Number: 19027267
• Product Code: CDP
• UDI-Device Identifier: 00380740144814
• UDI-Public: 00380740144814
• Combination Product (Y/N): N
• Initial Reporter Country: AR
• PMA/510(K) Number: EXEMPT
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: foreign,health professional
• Initial Reporter Occupation: Other Health Care Professional
• Remedial Action: Notification
• Type of Report: Initial
• Report Date (Section B): 03/09/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 06/22/2020
• Device Catalogue Number: 07K63-27
• Device Lot Number: 06426UI00
• Was Device Available for Evaluation?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 02/27/2020
• Initial Report FDA Received Date: 03/09/2020
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: 3005094123-10/22/18-001
• Patient Sequence Number: 1